Records 1 - 3
| Attainment of complete/very good partial response following rituximab-based therapy is an important determinant to progression-free survival, and is impacted by polymorphisms in FCGR3A in Waldenstrom macroglobulinaemia.
British journal of haematology 2011 Jul 154 (2): 223-8.
Treon Steven P, Yang Guang, Hanzis Christine, Ioakimidis Leukothea, Verselis Sigitas J, Fox Edward A, Xu Lian, Hunter Zachary R, Tseng Hsiuyi, Manning Robert J, Patterson Christopher J, Sheehy Patricia, Turnbull Bar
| FCGR3A gene polymorphisms may correlate with response to frontline R-CHOP therapy for diffuse large B-cell lymphoma.
Blood 2006 Oct 108 (8): 2720-5.
Kim Dong Hwan, Jung Hee Du, Kim Jong Gwang, Lee Je-Jung, Yang Deok-Hwan, Park Yeon Hee, Do Young Rok, Shin Ho Jin, Kim Min Kyoung, Hyun Myung Soo, Sohn Sang Ky
| The influence of genetic variation in the HLA-DRB1 and LTA-TNF regions on the response to treatment of early rheumatoid arthritis with methotrexate or etanercept.
Arthritis and rheumatism 2004 Sep 50 (9): 2750-6.
Criswell Lindsey A, Lum Raymond F, Turner Kevin N, Woehl Blanche, Zhu Yuanqing, Wang Jinyi, Tiwari Hemant K, Edberg Jeffrey C, Kimberly Robert P, Moreland Larry W, Seldin Michael F, Bridges S Lou